Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab and Irinotecan in RAS Wild-type Advanced Colorectal Cancer
NCT04833036Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Oct 2019
- Primary completion
- Jan 2022
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in colorectal cancer (CRC), sponsored by Fudan University. Status: unknown.
02
Drugs
cetuximab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT04833036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04833036.